Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1995-05-31
1997-04-15
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241531, 4241731, 4241781, 5303917, 53038873, 5303896, 435 7021, 4351722, C07K 1646, A01K 39395, C12N 1585
Patent
active
056206860
ABSTRACT:
Diseases attribute to a predominantly cell-mediated immune response, notably autoimmune diseases, can be suppressed by administering a novel conjugate of an appropriate antigen, notably an autoantigen, with antibody to an appropriate B cell surface molecule, such as IgD.
REFERENCES:
patent: 4792447 (1988-12-01), Uhr et al.
patent: 5045451 (1991-09-01), Uhr et al.
T.R. Mosmann et al., "TH1 and TH2 Cells: Different patterns of lymphokine secretion lead to different functional properties," Ann. Rev. Immunol 1, 145-73 (1989).
M.D. Sadick et al., "Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody", J. Exp. Med. 171, 115-127 (1990).
F.D. Finkelman et al., "Production of BSF-1 during an in vivo T-dependent immune response", J. Immunol. 137, 2878-2885 (1986).
K.A. Krolick et al., "Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin", Proc. Natl. Acad. Sci. USA 77, 5419-5423 (1980).
A. Lees et al., "Induction of large, rapid, specific antibody responses with antigen-anti-IGD antibody conjugates". FASEB Journal, 4, (7), A1804 (1990) (Joint Meeting Am. Soc. Biochem. and Mol. Biol. & Am. Assoc. Immunol. New Orleans USA, Jun. 4-7, 1990).
D.P. Snider et al., "Enhanced antigen immunogenicity induced by bispecific antibodies", J. Exp.Med. 171, 1957-1963 (1990).
S. Mjaaland et al., "Modulation of immune responses with monoclonal antibodies I. Effects on regional lymph node morphology and on anti-hapten responses to haptenized monoclonal antibodies" Eur. J. Immunol 20, 1457-1461 (1990).
R.E. Randall et al., "Humoral and cytotoxic T Cell Immune responses to internal and external structural proteins of Simian Virus 5 induced by immunization with solid matrix-antibody-anitgen complexes", J. Gen. Virol. 69, 2505-2516 (1988).
C. Snapper et al., "Murine B cells expressing Thy-1 after in vivo immunization selectively secrete IgE", J. Immunol. 144 (8), 2940-2945 (Apr. 1990).
K. Ota et al., "T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis", Nature 346, 183-187 (12 Jul. 1990).
Abramowicz et al., The New England Journal of Medicine, p. 736, (Sep. 3, 1992).
Waldmann, Science, vol. 252, pp. 1657-1662 (1991).
Harris et al., TIBTECH. vol. 11, pp. 42-44 (1993).
Hawkins et al., BMJ, vol. 305, pp. 1348-1352 (Nov. 28, 1992).
Borrebaeck, Journal of Immunological Methods vol. 123, pp. 157-165 (1989).
Wells et al., Basic & Clinical Immunology, Fudenberg et al. (Eds), LANGE Medical Publications, Calif., pp. 390-409 (1976).
Byers et al., Basic & Clinical Immunology, Fudenberg et al, (Eds), LANGE Medical Publications, Calif., pp. 242-259 (1976).
British Technology Group Limited
Nucker Christine M.
Reeves Julie E.
LandOfFree
Antigen-antibody conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen-antibody conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen-antibody conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-358791